Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
Fifty 410 at a Glance
- What it is
- Prepaid 3-month programs with no subscription and explicit 503A/503B disclosure
- Medication type
- Compounded only
- Medications offered
- Compounded tirzepatide (GLP-1/GIP)
- Compounded semaglutide
- Pricing
- Tirzepatide from $133/mo ($399 per 3-month program); semaglutide from $199/mo
- Insurance
- Cash-pay. Compounded medication is not covered by insurance.
- Date reviewed
- August 5, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is Fifty 410?
Two things set Fifty 410 apart. First, there is no subscription — you buy a 3-month program outright, and nothing renews behind your back.
Second, it states on its pricing pages that its tirzepatide is compounded by independent FDA-registered 503A and 503B compounding pharmacies. Naming the facility <em>type</em> is not the same as naming the pharmacy, but it is more than most competitors disclose, and the 503A/503B distinction genuinely matters — 503B outsourcing facilities operate under tighter FDA oversight.
Pricing is published per program tier: a Starter tirzepatide program at $133/month ($399 total) and a Mid Dose program at $166/month ($499 total), with semaglutide starting at $199/month.
How the Program Works
- Consultation process
- Online intake and clinician review; Fifty 410 states no subscription is required.
- Eligibility
- Clinician-assessed through the intake.
- Provider involvement
- Licensed providers review and prescribe. This is a medication program rather than a coaching service.
- Lab requirements
- Not published as a universal requirement.
- Pharmacy fulfillment
- Fifty 410 states its tirzepatide is compounded by independent FDA-registered 503A and 503B compounding pharmacies. It does not name individual pharmacies, but disclosing the facility type is more than most competitors do.
- Shipping frequency
- Programs are sold as 3-month blocks; medication is supplied for that period.
- Support services
- Provider oversight within the program. Minimal coaching.
Fifty 410 Pricing
- Membership fee
- None — Fifty 410 states no subscription is required, you pay only for the program.
- Medication fee
- Published 3-month tirzepatide programs: Starter at $133/month ($399 total, personalized starting dose) and Mid Dose at $166/month ($499 total, 144mg total). Its homepage states compounded tirzepatide or semaglutide starting at $199/month, with compounded medications starting at $133/month.
- Cancellation policy
- Nothing to cancel — there is no subscription. The 3-month program you buy is the commitment.
- Refund policy
- Not published as a general policy. A prepaid 3-month program is the financial exposure.
- Insurance
- Cash-pay. Compounded medication is not covered by insurance.
- HSA / FSA
- Commonly HSA/FSA-eligible. Confirm with your administrator.
Pricing details worth knowing
- You buy a 3-month program up front rather than subscribing.
- Pricing is tiered by dose, so higher doses cost more — check the tier that matches your maintenance dose.
- The homepage "$199/month" and pricing-page "$133/month" figures refer to different products and tiers.
Prices change. Every figure above was taken from Fifty 410's published pages or the named sources at the bottom of this review, as of August 5, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- No subscription and no auto-renewal
- Discloses that it uses FDA-registered 503A and 503B compounding pharmacies
- Low entry pricing on the starter tirzepatide program
- Program totals published up front, so you know the full commitment
Cons
- Dose-tiered pricing means your cost rises as you titrate
- Discloses facility type but not individual pharmacy names
- Prepaid 3-month blocks are a poor fit if you are unsure about tolerance
- Little support or coaching
Who Fifty 410 May Be Best For
People who want to avoid recurring subscriptions entirely
Anyone who cares about compounding-facility oversight
Patients starting at a low tirzepatide dose
Limitations
The advertised entry price is a starter-dose price — check the mid and higher tiers
Compounded medication carries the regulatory caveats described below
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has signaled further action. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to Fifty 410 — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to Fifty 410
Ondra Health
Names individual pharmacies and holds price flat at every dose
Read review →Brello Health
Also prepaid quarterly, with flat dose pricing
Read review →Yucca Health
Lower pricing on 3- and 6-month plans
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats Fifty 410 for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
Does Fifty 410 require a subscription?
No. Fifty 410 states no subscription is required — you buy a 3-month program outright. Its published tirzepatide programs are $399 total ($133/month) for the starter tier and $499 total ($166/month) for the mid-dose tier.
Where does Fifty 410 get its medication?
It states that its tirzepatide is compounded by independent FDA-registered 503A and 503B compounding pharmacies. It does not name individual pharmacies, but disclosing the facility type is more than most competitors do — 503B outsourcing facilities operate under tighter FDA oversight than 503A pharmacies.
The Verdict
Fifty 410 sells GLP-1 treatment as prepaid 3-month programs rather than subscriptions — tirzepatide from $133/month ($399 total) — and states plainly that its medications are compounded by independent FDA-registered 503A and 503B pharmacies.
Opens Fifty 410's official site · Verify current pricing there
Compare Every Provider Side by Side
See how Fifty 410 stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 5, 2026 from Fifty 410's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where Fifty 410 does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- fifty410.com/pricing and /pricing/tirzepatide (3-month program pricing)
- fifty410.com/pricing/semaglutide (503A and 503B disclosure, no-subscription statement)
- fifty410.com (starting price statements)
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.